Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.Richard Görlick, Barry Anderson, G. Peter Beardsley et al.|PubMed|2003Cited by 198
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing SarcomaPaul A. Meyers, Joseph A. Ludwig, Noah Federman et al.|Journal of Clinical Oncology|2024Cited by 36